# Higher Dose Intradermal H5 Vaccine

> **NCT00439335** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 227 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated Influenza A Vaccine A/H5N1
- **BIOLOGICAL:** Inactivated Influenza A Vaccine A/H5N1
- **DRUG:** Placebo (IM)
- **DRUG:** Placebo (ID)

## Key facts

- **NCT ID:** NCT00439335
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2013-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439335, "Higher Dose Intradermal H5 Vaccine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00439335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*